These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Caveolin-1 regulates γ-secretase-mediated AβPP processing by modulating spatial distribution of γ-secretase in membrane. Kapoor A; Hsu WM; Wang BJ; Wu GH; Lin TY; Lee SJ; Yen CT; Liang SM; Liao YF J Alzheimers Dis; 2010; 22(2):423-42. PubMed ID: 20847442 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation. Kim Y; Kim C; Jang HY; Mook-Jung I J Alzheimers Dis; 2016; 51(4):1057-68. PubMed ID: 26923021 [TBL] [Abstract][Full Text] [Related]
44. Enhanced amyloid-β generation by γ-secretase complex in DRM microdomains with reduced cholesterol levels. Hata S; Hu A; Piao Y; Nakaya T; Taru H; Morishima-Kawashima M; Murayama S; Nishimura M; Suzuki T Hum Mol Genet; 2020 Feb; 29(3):382-393. PubMed ID: 31841137 [TBL] [Abstract][Full Text] [Related]
45. Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma. Zhou Y; Suram A; Venugopal C; Prakasam A; Lin S; Su Y; Li B; Paul SM; Sambamurti K FASEB J; 2008 Jan; 22(1):47-54. PubMed ID: 17666454 [TBL] [Abstract][Full Text] [Related]
46. Spatial segregation of gamma-secretase and substrates in distinct membrane domains. Vetrivel KS; Cheng H; Kim SH; Chen Y; Barnes NY; Parent AT; Sisodia SS; Thinakaran G J Biol Chem; 2005 Jul; 280(27):25892-900. PubMed ID: 15886206 [TBL] [Abstract][Full Text] [Related]
47. The involvement of lipid rafts in Alzheimer's disease. Cordy JM; Hooper NM; Turner AJ Mol Membr Biol; 2006; 23(1):111-22. PubMed ID: 16611586 [TBL] [Abstract][Full Text] [Related]
48. Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. Tun H; Marlow L; Pinnix I; Kinsey R; Sambamurti K J Mol Neurosci; 2002; 19(1-2):31-5. PubMed ID: 12212790 [TBL] [Abstract][Full Text] [Related]
49. Presenilin 1 regulates pharmacologically distinct gamma -secretase activities. Implications for the role of presenilin in gamma -secretase cleavage. Murphy MP; Uljon SN; Fraser PE; Fauq A; Lookingbill HA; Findlay KA; Smith TE; Lewis PA; McLendon DC; Wang R; Golde TE J Biol Chem; 2000 Aug; 275(34):26277-84. PubMed ID: 10816583 [TBL] [Abstract][Full Text] [Related]
50. Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts. Kosicek M; Malnar M; Goate A; Hecimovic S Biochem Biophys Res Commun; 2010 Mar; 393(3):404-9. PubMed ID: 20138836 [TBL] [Abstract][Full Text] [Related]
51. gamma-Secretase: characterization and implication for Alzheimer disease therapy. Xu M; Lai MT; Huang Q; DiMuzio-Mower J; Castro JL; Harrison T; Nadin A; Neduvelil JG; Shearman MS; Shafer JA; Gardell SJ; Li YM Neurobiol Aging; 2002; 23(6):1023-30. PubMed ID: 12470798 [TBL] [Abstract][Full Text] [Related]
52. Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface. Guardia-Laguarta C; Coma M; Pera M; Clarimón J; Sereno L; Agulló JM; Molina-Porcel L; Gallardo E; Deng A; Berezovska O; Hyman BT; Blesa R; Gómez-Isla T; Lleó A J Neurochem; 2009 Jul; 110(1):220-30. PubMed ID: 19457132 [TBL] [Abstract][Full Text] [Related]
53. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Sambamurti K; Suram A; Venugopal C; Prakasam A; Zhou Y; Lahiri DK; Greig NH Curr Alzheimer Res; 2006 Feb; 3(1):81-90. PubMed ID: 16472208 [TBL] [Abstract][Full Text] [Related]
54. Generation of monoclonal antibody fragments binding the native γ-secretase complex for use in structural studies. Alattia JR; Schweizer C; Cacquevel M; Dimitrov M; Aeschbach L; Oulad-Abdelghani M; Fraering PC Biochemistry; 2012 Nov; 51(44):8779-90. PubMed ID: 23066899 [TBL] [Abstract][Full Text] [Related]
55. Down-regulation of endogenous amyloid precursor protein processing due to cellular aging. Kern A; Roempp B; Prager K; Walter J; Behl C J Biol Chem; 2006 Feb; 281(5):2405-13. PubMed ID: 16303768 [TBL] [Abstract][Full Text] [Related]
56. Membrane anchored and lipid raft targeted β-secretase inhibitors for Alzheimer's disease therapy. Ben Halima S; Rajendran L J Alzheimers Dis; 2011; 24 Suppl 2():143-52. PubMed ID: 21460437 [TBL] [Abstract][Full Text] [Related]
57. Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Xiong H; Callaghan D; Jones A; Walker DG; Lue LF; Beach TG; Sue LI; Woulfe J; Xu H; Stanimirovic DB; Zhang W Neurobiol Dis; 2008 Mar; 29(3):422-37. PubMed ID: 18086530 [TBL] [Abstract][Full Text] [Related]
58. Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms. Parsons RB; Price GC; Farrant JK; Subramaniam D; Adeagbo-Sheikh J; Austen BM Biochem J; 2006 Oct; 399(2):205-14. PubMed ID: 16803455 [TBL] [Abstract][Full Text] [Related]
59. Modulation of lipid kinase PI4KIIα activity and lipid raft association of presenilin 1 underlies γ-secretase inhibition by ginsenoside (20S)-Rg3. Kang MS; Baek SH; Chun YS; Moore AZ; Landman N; Berman D; Yang HO; Morishima-Kawashima M; Osawa S; Funamoto S; Ihara Y; Di Paolo G; Park JH; Chung S; Kim TW J Biol Chem; 2013 Jul; 288(29):20868-20882. PubMed ID: 23723072 [TBL] [Abstract][Full Text] [Related]